Skip to main content

iwCLL 2025 Main banner

iwCLL X / Twitter

152 Views

Poster

1432 - Title: A phase Ib study evaluating the safety and efficacy of tafasitamab, acalabrutinib, and obinutuzumab (TAO) in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma

Primary Author / Presenter(s)

CE

Chaucie Edwards, TI Sr Clinical Research Assistant

OHSU
Portland, Oregon, United States

Co-Author(s)

TS

Tanaya Shree, MD

OHSU
Portland, Oregon, United States
CO

Craig Okada, MD

OHSU
Portland, Oregon, United States
PS

Pamela St. Clair, NP

OHSU
Portland, Oregon, United States
NF

Narcy Foraker, NP

OHSU
Portland, Oregon, United States
TB

Titas Banerjee, MD

OHSU
Portland, Oregon, United States
SW

Sarah West, Data Research

OHSU
Portland, Oregon, United States
KD

Kayleigh Day, Oncology Clinical Research Mgr

OHSU
Portland, Oregon, United States
AE

Annie Evans, TI Sr Clinical Research Assistant

OHSU
Portland, Oregon, United States
SM

Shashi Mendis, TI Clinical Research Associate

OHSU
Portland, Oregon, United States
DR

Debbie Ryan, RN

OHSU
Portland, Oregon, United States
BP

Byung Park, PhD

Associate Professor
Knight Cancer Institute, OHSU
Portland, Oregon, United States
SS

Stephen Spurgeon, MD

Oregon Health and Science University
Portland, Oregon, United States